Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 295.60
+18.70 (6.75%)
Apr 8, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 20.87 billion as of April 8, 2026. Its market cap has decreased by -48.93% in one year.
Market Cap
20.87B
Enterprise Value
6.17B
Revenue
9.21B
Ranking
n/a
PE Ratio
3.28
Stock Price
295.60
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 20.87B, an increase of 1,384.97%. That is a compound annual growth rate of 19.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 19.55B | -40.48% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.05T |
| Genmab | 107.96B |
| Coloplast | 99.70B |
| ALK-Abelló | 45.60B |
| Demant | 41.25B |
| H. Lundbeck | 39.07B |
| Ambu A/S | 18.31B |
| Bavarian Nordic | 15.11B |